The company added that the device will be indicated for both paroxysmal and persistent atrial fibrillation. Citing data from its PULSED AF study, Medtronic (MDT) said that the PulseSelect PFA ...

The hit to demand for spinal devices from deferred procedures pulled down revenue from the neuroscience unit in Q2 2022 ...

Paid and presented by Medtronic. The growing application of digital health technologies is advancing the capabilities of insertable cardiac devices. The most recent iterations can connect to a ...

Medtronic's miniature leadless pacemaker, the Micra Transcatheter Pacing System (TPS), is expected to secure FDA approval during the company's 2017 fiscal year. That stretches from May 2016 through ...

The Centers for Medicare & Medicaid Services granted transitional pass-through (TPT) payment status to Medtronic and Recor Medical for renal denervation devices to treat high blood pressure.

Investing.com -- Medtronic (NYSE:MDT) has raised its annual revenue and earnings outlook following "broad-based, diversified" growth across several of the medical device manufacturer's businesses ...

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves ...

The FDA recently announced critical recalls on several widely used medical devices, including Life2000 ventilators, Medtronic's MiniMed insulin pumps and Boston Scientific's Obsidio conformable ...

2024 (and announced by FDA on October 17), the company issued an “Urgent Medical Device Correction” letter, advising users to do the following: From January 2023 to September 2024, Medtronic ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...